Posted Sep. 8, 2011 at 12:37 p.m.

Premium Lock Losers in Treximet patent decision are appealing

Published: 2011-09-08 12:37:20
Updated: 2011-09-08 12:37:20

Print this blog post
Pozen
Tags: Pozen, GSK

A securities filing by patent-holder Pozen says that generic drug-makers are appealing a ruling by a judge in that Pozen had exclusive rights to Treximet....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll